• to reduce the risk of severe cardiovascular (heart and blood vessel) complications in Grown ups with type 2 diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched options for an experimental weight loss pill in May but remains to be hoping for the slice of the marketplace with MariTide, a month to month injection that's ta